UK markets open in 2 hours 37 minutes

Aptinyx Inc. (APTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.8200+0.1700 (+6.42%)
At close: 04:00PM EST
2.8200 0.00 (0.00%)
After hours: 07:24PM EST
Full screen
Trade prices are not sourced from all markets
Previous close2.6500
Open2.6700
Bid2.4000 x 1100
Ask2.9500 x 1400
Day's range2.6000 - 2.8200
52-week range2.0600 - 4.7300
Volume136,789
Avg. volume183,919
Market cap190.958M
Beta (5Y monthly)1.34
PE ratio (TTM)N/A
EPS (TTM)-1.0270
Earnings date22 Mar 2022 - 28 Mar 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est9.20
  • Zacks

    Is Opexa Therapeutics, Inc. (ACER) Outperforming Other Medical Stocks This Year?

    Here is how Opexa Therapeutics, Inc. (ACER) and Aptinyx Inc. (APTX) have performed compared to their sector so far this year.

  • Business Wire

    Aptinyx Highlights Key Goals and Anticipated Development Milestones for 2022

    EVANSTON, Ill., January 06, 2022--Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today provided a corporate update and highlighted development milestones anticipated in 2022.

  • Business Wire

    Aptinyx to Host Virtual Portfolio Review Event on February 9th, 2022

    EVANSTON, Ill., December 20, 2021--Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that it will host a virtual portfolio review event on Wednesday, February 9, 2022 from 10:00 a.m. to 11:30 a.m. ET. The live webcast event will review Aptinyx’s full pipeline of clinical development programs, with particular focus on NYX-2925, the company’s drug candidate in developm